SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck. Symptoms include, head ...
Explore causes, symptoms and diagnosis of Giant Cell Arteritis and Temporal Arteritis including headache, vision loss and jaw ...
The Global Healthy Living Foundation (GHLF), parent non-profit of the CreakyJoints® online patient community, today announced ...
At week 52 in a randomized, controlled trial, results suggest that tocilizumab is more effective than methotrexate in ...
A 78-year-old man was referred for an ultrasound of his right eye to evaluate a small choroidal nevus. He also mentioned almost total loss of vision in his left eye over the past several days. His ...
Learn about polymyalgia rheumatica, temporal arteritis, their symptoms, causes, and treatment options to manage pain, ...
Findings showed 46% of patients who received upadacitinib 15mg achieved sustained remission at week 52 compared with 29% of patients who received placebo. Patients with giant cell arteritis (GCA) who ...
MedPage Today on MSN
JAK Inhibitor Stays Effective Beyond 1 Year for Giant Cell Arteritis
Results from the trial's first year were reported at the 2024 ACR meeting, and they persuaded the FDA to approve the drug for ...
Please provide your email address to receive an email when new articles are posted on . Patients who abruptly discontinued tocilizumab had significantly shorter time to relapse than those who tapered.
Findings showed 46.4% of patients treated with upadacitinib 15mg achieved sustained remission compared with 29.0% of those who received placebo. The Food and Drug Administration (FDA) has approved ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Senescence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results